Company Filing History:
1 out of 8 
1 out of 1,942 
1 out of 3,688 
Years Active: 2013
Title: Richard Dalby: Innovator in Intraepithelial Neoplasia Treatment
Introduction
Richard Dalby is a notable inventor based in Timonium, MD (US). He has made significant contributions to the field of medical treatments, particularly focusing on intraepithelial neoplasia. His innovative work has led to the development of a patent that addresses this critical health issue.
Latest Patents
Richard Dalby holds a patent for "Methods and compositions for treatment of intraepithelial neoplasia." This invention provides compositions, kits, and methods for treating intraepithelial neoplasia, utilizing catecholic butanes, including NDGA derivatives. This advancement represents a promising approach to managing a challenging medical condition.
Career Highlights
Throughout his career, Richard has worked with various organizations, including Erimos Pharmaceuticals, LLC and the University System of Maryland. His experience in these institutions has allowed him to collaborate with other professionals and contribute to significant advancements in medical research.
Collaborations
Richard has collaborated with notable individuals in his field, including Neil Frazer and Jonathan Daniel Heller. These partnerships have enhanced his research and development efforts, leading to innovative solutions in the treatment of intraepithelial neoplasia.
Conclusion
Richard Dalby is a dedicated inventor whose work in the treatment of intraepithelial neoplasia has the potential to impact many lives positively. His contributions to medical science through his patent and collaborations highlight the importance of innovation in healthcare.